伤残权重方法学研究进展

胡葵茹; 万霞

doi:10.11847/zgggws1134564

伤残权重方法学研究进展

doi: 10.11847/zgggws1134564

胡葵茹,
万霞^,

中国医学科学院基础医学研究所暨北京协和医学院基础学院, 北京 100005

基金项目: 中国医学科学院医学与健康科技创新工程 (2016 – I2M – 3 – 001)；中华医学基金会项目 (15 – 208)

详细信息

作者简介:
胡葵茹（1995 – ），女，陕西渭南人，硕士在读，研究方向：疾病负担

通讯作者:
万霞，E-mail：xiawan@ibms.pumc.edu.cn

中图分类号: R 195.1
计量
- 文章访问数: 658
- HTML全文浏览量: 246
- PDF下载量: 36
- 被引次数: 0
出版历程
- 接收日期: 2021-03-06
- 网络出版日期: 2022-03-23
- 刊出日期: 2022-07-01

Progress in researches on methodology of disability weight

HU Kui-ru,
WAN Xia^,

Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and School of Basic Medicine, Peking Union Medical College, Beijing 100005, China

摘要

摘要: 伤残权重（DW）表示某特定伤残状态健康损失的严重程度，是估算伤残调整生命年（DALY）的一个重要指标。目前DW估算主要分为基于全球疾病负担的伤残权重（GBD DW）和基于健康相关生命质量的健康状态权重（HRQOL HSW）2种。为促进DW的进一步发展，本文对DW这2种方法学研究的评估人群、健康状态定义和评估方法进行了综述比较，从而分析不同方法的优缺点，为DW研究方法的改进提供综合参考依据。
- 伤残权重（DW） /
- 方法学 /
- 研究进展
Abstract: Disability weight (DW), one of important indicators for estimating disability-adjusted life years (DALY), represents the severity of health loss in a particular disability state. Currently, DW has two sets of methodology named as “disability weight from the Global Burden of Disease Study” (GBD DW) and “health status weight from Health-Related Quality of Life” (HRQOL HSW). In order to promote the further development of DW methodology, this study briefly reviewed and compared these two sets of methodological study, including the respondents for the assessment, definition of health status, assessment methods and the methods' strength and weakness, which would provide a comprehensive reference for the improvement of DW research.
- disability weight /
- methodology /
- research progress

HTML全文

参考文献(27)

[1]	Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future direc-tions[J]. Bulletin of the World Health Organization, 1994, 72(3): 495 – 509.
[2]	Murray CJ. Quantifying the burden of disease: the technical basis for disability - adjusted life years[J]. Bulletin of the World Health Organization, 1994, 72(3): 429 – 445.
[3]	董惠玲, 吴炳义, 武继磊, 等. 健康预期寿命与伤残调整生命年内在关联与差异[J]. 中国公共卫生, 2020, 36(11): 1645 – 1650. doi: 10.11847/zgggws1123823
[4]	Haagsma JA, Polinder S, Cassini A, et al. Review of disability weight studies: comparison of methodological choices and values[J]. Population Health Metrics, 2014, 12(1): 20. doi: 10.1186/s12963-014-0020-2
[5]	Dolan P. Modeling valuations for EuroQol health states[J]. Medical Care, 1997, 35(11): 1095 – 1108. doi: 10.1097/00005650-199711000-00002
[6]	Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ - 5D health states[J]. Medical Care, 2005, 43(3): 203 – 220. doi: 10.1097/00005650-200503000-00003
[7]	Stouthard MEA, Essink-Bot ML, Bonsel GJ, et al. Disability weights for diseases in the Netherlands[M]. Amsterdam: Inst. Sociale Geneeskunde, 1997.
[8]	Murray CJL, Lopez AD. The global burden of disease: a comprehen-sive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020[M]. Cambridge: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
[9]	Schwarzinger M, Stouthard ME, Burström K, et al. Cross - national agreement on disability weights: the European Disability Weights Project[J]. Population Health Metrics, 2003, 1(1): 9. doi: 10.1186/1478-7954-1-9
[10]	Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study[J]. The Lancet Global Health, 2015, 3(11): e712 – e723. doi: 10.1016/S2214-109X(15)00069-8
[11]	Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics[J]. The Lancet, 2012, 380(9859): 2063 – 2066. doi: 10.1016/S0140-6736(12)61899-6
[12]	James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990 – 2017: a systematic analysis for the global burden of disease study 2017[J]. The Lancet, 2018, 392(10159): 1789 – 1858. doi: 10.1016/S0140-6736(18)32279-7
[13]	Jelsma J, Chivaura VG, Mhundwa K, et al. The global burden of disease disability weights[J]. The Lancet, 2000, 355(9220): 2079 – 2080. doi: 10.1016/S0140-6736(05)73538-8
[14]	Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010[J]. The Lancet, 2012, 380(9859): 2129 – 2143. doi: 10.1016/S0140-6736(12)61680-8
[15]	Taylor HR, Jonas JB, Keeffe J, et al. Disability weights for vision disorders in global burden of disease study[J]. The Lancet, 2013, 381(9860): 23.
[16]	Nord E. Disability weights in the Global Burden of Disease 2010: unclear meaning and overstatement of international agreement[J]. Health Policy, 2013, 111(1): 99 – 104. doi: 10.1016/j.healthpol.2013.03.019
[17]	Liu GG, Wu HY, Li MH, et al. Chinese time trade - off values for EQ - 5D health states[J]. Value in Health, 2014, 17(5): 597 – 604. doi: 10.1016/j.jval.2014.05.007
[18]	伍红艳, 孙利华. EQ-5D量表效用值积分体系构建的国际研究新进展[J]. 中国卫生经济, 2012, 31(10): 94 – 96.
[19]	陈天辉, 李鲁, Single JM, 等. 健康相关生命质量测量工具SF-36第二版和第一版的比较[J]. 中国社会医学杂志, 2006, 23(2): 111 – 114. doi: 10.3969/j.issn.1673-5625.2006.02.013
[20]	Tsuchiya A, Ikeda S, Ikegami N, et al. Estimating an EQ - 5D population value set: the case of Japan[J]. Health Economics, 2002, 11(4): 341 – 353. doi: 10.1002/hec.673
[21]	刘笑晗, 李顺平, 陈钢. SF-6D量表不同国家和地区效用积分体系的比较[J]. 中国卫生经济, 2019, 38(12): 5 – 8.
[22]	刘志, 郑研辉, 郝晓宁. 北京市居家老年人健康生命质量现状及影响因素分析[J]. 人口与健康, 2021(7): 42 – 45.
[23]	赵华硕, 王可, 金英良, 等. 农村空巢老人SF-36量表应用信度及效度评价[J]. 中国公共卫生, 2012, 28(7): 887 – 889. doi: 10.11847/zgggws-2012-28-07-03
[24]	Gobbens RJJ, Van Der Ploeg T. The prediction of mortality by quality of life assessed with the WHOQOL - BREF: a longitudinal analysis at the domain and item levels using a seven - year follow - up period[J]. Quality of Life Research, 2021, 30(7): 1951 – 1962. doi: 10.1007/s11136-021-02790-9
[25]	田艳梅, 肖文文, 乔慧. 宁夏5县农村老年人生命质量及影响因素分析[J]. 中国公共卫生, 2021, 37(1): 1 – 4. doi: 10.11847/zgggws1124163
[26]	Toet J, Raat H, Van Ameijden EJ. Validation of the Dutch version of the CDC core healthy days measures in a community sample[J]. Quality of Life Research, 2006, 15(1): 179 – 184. doi: 10.1007/s11136-005-8484-y
[27]	Centers for Disease Control and Prevention. CDC HRQOL-14 “Healthy Days Measure”[EB/OL]. (2018 – 10 – 31)[2021 – 09 – 23]. https://www.cdc.gov/hrqol/hrqol14_measure.htm.